Background Poor representation of pregnant and lactating women and people in clinical trials has marginalised their health concerns and denied the maternal–fetal/infant dyad benefits of innovation in
Data quality in clinical notes is crucial for providing quality prostate cancer services, especially in countries with weak health systems and a growing burden of non-communicable diseases like prosta